Literature DB >> 9391557

The actinic keratosis. A perspective and update.

R A Schwartz1.   

Abstract

BACKGROUND: Actinic keratosis (AK) is a common sun-induced precancerous neoplasm confined to the epidermis. It is the initial manifestation of a continuum of clinical and histologic abnormalities that progresses to invasive squamous cell carcinoma (SCC), a disorder that accounts for thousands of preventable deaths in America each year.
OBJECTIVE: The purpose of this work is to describe the actinic keratosis.
METHODS: This effort was performed by a literature review and analysis.
RESULTS: Like SCCs, the vast majority of AKs are asymptomatic. Although some actinic keratoses may become clinically inapparent, possibly either due to immune rejection or simply having their external surface unknowingly scraped off, an untreated AK represents a potentially curable fatal cancer.
CONCLUSIONS: Each AK should be treated before it progresses to invasive squamous cell carcinoma. Destructive modalities such as cryosurgery using liquid nitrogen and electrodesiccation and curettage are the mainstays of therapy. Each case must be individualized. LEARNING
OBJECTIVES: After studying this article, participant should be able to: 1. Understand the concept of an actinic keratosis. 2. Learn how to recognize its clinical manifestations. 3. Be aware of the danger it poses as an easily curable papulonodule that may become a fatal cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9391557     DOI: 10.1111/j.1524-4725.1997.tb00438.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  9 in total

1.  Long-term Follow up of Diclofenac Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One-year Evaluation.

Authors:  Christopher Nelson; Darrell Rigel
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

2.  Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.

Authors:  Abel Torres; Leslie Storey; Makala Anders; Richard L Miller; Barbara J Bulbulian; Jizhong Jin; Shalini Raghavan; James Lee; Herbert B Slade; Woubalem Birmachu
Journal:  J Transl Med       Date:  2007-01-26       Impact factor: 5.531

Review 3.  Interventions for actinic keratoses.

Authors:  Aditya K Gupta; Maryse Paquet; Elmer Villanueva; William Brintnell
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

4.  Defining Field Cancerization of the Skin Using Noninvasive Optical Coherence Tomography Imaging to Detect and Monitor Actinic Keratosis in Ingenol Mebutate 0.015%- Treated Patients.

Authors:  Orit Markowitz; Michelle Schwartz; Eleanor Feldman; Amy Bieber; Amanda Bienenfeld; Naveen Nandanan; Daniel M Siegel
Journal:  J Clin Aesthet Dermatol       Date:  2016-05-01

5.  Diclofenac gel in the treatment of actinic keratoses.

Authors:  Christopher G Nelson
Journal:  Ther Clin Risk Manag       Date:  2011-06-15       Impact factor: 2.423

Review 6.  Actinic Keratosis Clinical Practice Guidelines: An Appraisal of Quality.

Authors:  Joslyn S Kirby; Thomas Scharnitz; Elizabeth V Seiverling; Hadjh Ahrns; Sara Ferguson
Journal:  Dermatol Res Pract       Date:  2015-09-16

Review 7.  Hyaluronan and synovial joint: function, distribution and healing.

Authors:  Tamer Mahmoud Tamer
Journal:  Interdiscip Toxicol       Date:  2013-09

Review 8.  Photodynamic Therapy for Non-Melanoma Skin Cancers.

Authors:  Diana K Cohen; Peter K Lee
Journal:  Cancers (Basel)       Date:  2016-10-04       Impact factor: 6.639

9.  New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.

Authors:  Brian Berman
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.